As of July 2022 Antares Pharma has a market cap of $0.95 Billion. This makes Antares Pharma the world's 4380th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.95 B | 57.33% |
2021 | $0.60 B | -8.72% |
2020 | $0.66 B | -14.36% |
2019 | $0.77 B | 78.74% |
2018 | $0.43 B | 39.34% |
2017 | $0.31 B | -13.72% |
2016 | $0.36 B | 92.86% |
2015 | $0.18 B | -44.66% |
2014 | $0.33 B | -41.18% |
2013 | $0.57 B | 19.95% |
2012 | $0.47 B | 110.72% |
2011 | $0.22 B | 59.17% |
2010 | $0.14 B | 53.42% |
2009 | $0.09 B | 270.74% |
2008 | $0.02 B | -60.83% |
2007 | $0.06 B | 0.37% |
2006 | $0.06 B | -4.04% |
2005 | $0.06 B | 22.2% |
2004 | $0.05 B | 167.13% |
2003 | $0.02 B | 351.28% |
2002 | $4.52 M | -86.65% |
2001 | $0.03 B |
On Jul 6th, 2022 the market cap of Antares Pharma was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $467.75 B | 48,876.64% | ๐บ๐ธ USA |
![]() Pfizer PFE | $297.82 B | 31,083.98% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $311.98 B | 32,565.98% | ๐บ๐ธ USA |
![]() Becton Dickinson BDX | $70.24 B | 7,255.09% | ๐บ๐ธ USA |
![]() ANI Pharmaceuticals ANIP | $0.53 B | -43.69% | ๐บ๐ธ USA |
![]() Retractable Technologies RVP | $0.13 B | -85.67% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | $8.34 B | 773.69% | ๐ฎ๐ฑ Israel |
![]() West Pharmaceutical WST | $23.47 B | 2,358.45% | ๐บ๐ธ USA |